Orb Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.15 M
- Company Age 18 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.52 M
- Revenue Growth -44.42%
- Profit Growth -14.05%
- Ebitda -108.12%
- Net Worth 23.50%
- Total Assets -4.82%
About Orb Pharma
Orb Pharma Private Limited (OPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 February 2006 and has a history of 18 years and 11 months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹1.52 M.
Ranjeet Kumar, Jai Singh, and Dharmendra Singh serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232DL2006PTC146702
-
Company No.
146702
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Feb 2006
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Orb Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ranjeet Kumar
|
Director | 22-Feb-2006 | Current |
|
Jai Singh
|
Director | 22-Feb-2006 | Current |
|
Dharmendra Singh
|
Director | 28-Feb-2019 | Current |
Financial Performance of Orb Pharma.
Orb Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 44.42% decrease. The company also saw a substantial fall in profitability, with a 14.05% decrease in profit. The company's net worth Soared by an impressive increase of 23.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Orb Pharma?
In 2021, Orb Pharma had a promoter holding of 66.67% and a public holding of 33.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.52 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.15 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Feb 2019 | Others | ₹1.52 M | Open |
How Many Employees Work at Orb Pharma?
Unlock and access historical data on people associated with Orb Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Orb Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orb Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
